management of hiv - post-exposure prophylaxis management of hiv - post-exposure prophylaxis

46
Occupational Exposure Management of HIV Post-Exposure Prophylaxis Bruce D. Agins, MD MPH Medical Director, AIDS Institute New York State Department of Health

Upload: medicineandhealthusa

Post on 07-May-2015

2.022 views

Category:

Health & Medicine


2 download

TRANSCRIPT

  • 1.Occupational ExposureManagement of HIVPost-Exposure Prophylaxis Bruce D. Agins, MD MPH Medical Director, AIDS Institute New York State Department of Health

2. Overview

  • Rationale: Science & Epidemiology
  • Guidelines: Recommendations & Controversies
  • Implementation: Guidance for Employers

3. RATIONALE

  • Magnitude of the problem
  • An opportunity for prevention
  • Known successes of HIV prophylaxis

4. Occupational HIV Infection

  • Occupationally acquired HIV infection among HCW reported through 6/99
    • 137 possible cases of HIV transmission
    • 57 documented cases of HIV infection
    • 26/57 AIDS
  • Most exposures do not result in infection

5. Occupational HIV Infection

  • Factors influencing transmission
    • Amount of blood involved in exposure
    • Amount of virus in patients blood at time of exposure
    • Post-exposure prophylaxis

6. U.S. Health-Care Workers with Documented Occupationally Acquired HIV Infection, by Occupation through June 1999

  • OCCUPATION
  • Nurse24
  • Clinical laboratory technician16
  • Physician(non-surgeon) 6
  • Non-clinical laboratory technician3
  • Surgical technician 2
  • Housekeeper / maintenance worker2
  • Morgue technician 1
  • Emergency med technician/paramedic 1
  • Respiratory therapist1
  • Dialysis technician1
  • Total57

7. Source Fluids for Exposures Resulting in Occupational HIV TransmissionUS HCW reported through 12/98 8. Risk Factors for HIV Transmission CDC Case Control Study

  • Risk Factor Adjusted Odds Ratio(95% CI)
  • Deep Injury 16.2(6.1-44.6)
  • Visible blood6 (1.8-17.7)
  • Terminal illness6 (2.2-18.9)
  • In vessel4 (1.9-14.8)
  • ZDV use 0.2 (0.1-0.6)
  • Cardo et al., NEJM;1997;337:1485-90 (updated)

9. Exposure Risk

  • Percutaneous0.3%
  • Mucous membrane0.1%
  • Non-intact skin